Jun 27
|
Sona Announces Ethics Committee Approval For Melanoma Clinical Trial
|
Jun 16
|
Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy
|
May 7
|
BioVaxys and Sona Nanotech Enter Research Collaboration
|
Feb 12
|
Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference
|
Oct 9
|
Sona Nanotech Grants Options
|
Jun 20
|
Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer
|
Jan 10
|
Sona Nanotech Announces Director Retirement
|
Nov 27
|
Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing
|